The FDA has warned that it will be coming down hard on anyone carrying out do-it-yourself gene therapy, in a recent statement.
One under the radar biotech could be trumping all its competitors, after it makes significant progress in potentially producing an Alzheimer’s treatment.
This Thanksgiving investors are thankful that the S&P 500 is up about 15% year to date, with that path expected to continue to the end of the year.
The three big players in the world of cloud computing released their quarterly earnings this week, and it’s clear who’s speeding ahead.
The FDA has released new guidelines in a bid to quicken the implementation of treatments involving human cells and tissues, including gene therapy.
Josiah Zayner, the scientist who left NASA to bring genetic engineering to consumers has modified his own genome with CRISPR (true DIY style).
With more money being plugged into battling antibiotic resistance, researchers have begun to consider synthetic biology as a new way to fight bacteria.
Moderna Therapeutics has began taking the steps to produce a cancer vaccine based on the growing volume of research on messenger RNA (mRNA).
In an attempt to make precision medicine the next mainstream, China are leading the way with Artificial Intelligence (AI).
Researchers have used CRISPR to genetically engineer a transgenic mosquitoe species, which could lead to the eventual eradication of a species.